MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer
Crossref DOI link: https://doi.org/10.17352/gjct.000019
Published Online: 2017-05-26
Update policy: https://doi.org/10.17352/crossmark-policy
Strauss, J
Version of Record valid from 2013-11-25
Accepted Manuscript valid from 2015-05-25